Nang Kuang Pharmaceutical Co., Ltd.

Taiwan Stock Exchange 1752.TW

Nang Kuang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2023: USD 8.47 M

Nang Kuang Pharmaceutical Co., Ltd. Operating Income is USD 8.47 M for the year ending December 31, 2023, a -37.86% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Nang Kuang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 13.62 M, a 61.57% change year over year.
  • Nang Kuang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 8.43 M, a 2.92% change year over year.
  • Nang Kuang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 8.19 M, a -4.30% change year over year.
  • Nang Kuang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 8.56 M, a 112.75% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
Taiwan Stock Exchange: 1752.TW

Nang Kuang Pharmaceutical Co., Ltd.

CEO Ms. Yu-Bei Wang
IPO Date Jan. 20, 2022
Location Taiwan
Headquarters No. 1001, Zhongshan Road
Employees 552
Sector Health Care
Industries
Description

Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, anticancer injectable, injectable controlled and oral controlled products, and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Similar companies

1783.TW

Maxigen Biotech Inc.

USD 1.58

0.31%

4104.TW

Excelsior Medical Co., Ltd.

USD 2.57

0.00%

4737.TW

Bionime Corporation

USD 1.81

0.29%

1734.TW

Sinphar Pharmaceutical Co.,Ltd.

USD 0.93

0.28%

StockViz Staff

January 15, 2025

Any question? Send us an email